Putting clinical trial participation within the context of a patient’s entire life experience.
BBK Worldwide is marking the evolution of the patient experience with the introduction of a new construct called study-life balance. It leverages patient-centric solutions to help patients more easily integrate clinical trial participation into their daily lives.
Insights from Advarra on Managing Changes to Patient Enrollment & Engagement due to COVID-19
Get an IRB's perspective on managing clinical trial enrollment modifications due to COVID-19 by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra.
For clinical trial sponsors, staying on top of the latest innovations can be a challenge, especially in an industry historically slow to adapt to change. But experts warn of the risk of falling behind, especially in light of advancing technologies that are impacting clinical trial enrollment and engagement.
While you may not be ready to embrace the use of a virtual self-service hologram—greeting patients in the doctor’s office with information about a clinical trial—there are a few key innovations that all clinical trial sponsors should keep on their radar. Below, we highlight three that are driving significant change.
All you need is a brief conversation with Andrew to understand why he’s our RSG® Arrive Driver of the Month. A native of the Philadelphia area, he has been an RSG® Arrive driver for over two years. His assignments include taking patients with progressive neurodegenerative diseases to and from their study appointments, at times traveling two hours each way. He recognizes the challenges that some of the patients face and always tries to find opportunities to lighten their day with a smile or light conversation. “I try to take their mind off where they are traveling and why – even if it’s for a brief moment.”
Season 2 Episode 2: As part of our Pharma15 Live! web series, we recently had the opportunity to sit down with three-time clinical trial participant Richard Brescia for a candid conversation about his experience – both positive and negative. As an industry, we can learn a tremendous amount by going directly to the heart of the matter and listening to the “patient voice.”
Georgia Mitsi spoke with BBK Worldwide®’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”
What does patient data ownership actually mean? According to Craig Lipset, head of clinical innovation at Pfizer and DPharm 2018 co-chair, that is still an open question. Pharma15 Live! chatted with him about it at the DPharm 2018 conference.
With regard to the adoption and use of digital health solutions in clinical R&D, where are we as an industry? In our latest Pharma15 Live! debate, BBK Worldwide® Founding Principal Bonnie A. Brescia posed this question to the panel of industry experts. Justin Johnson, CEO of Biotaware, answered in no uncertain terms: “[the industry] is five to eight years behind where it should be.” Do you agree?
There are probably a good number of us in the clinical research and development industry that are spending a lot of time dotting the i’s and crossing the t’s on their Privacy Policies and otherwise ensuring that everything is ready for the 25th of May, the day that the EU’s General Data Protection Regulation (GDPR) goes into effect. And, there are probably a good number of us who have had a rather intense schedule over the past few months. But, I bet if you conducted a poll, you’d find that despite all the time-consuming work and activity, those of us concerned with the patient experience are greatly pleased that GDPR is finally here.
Picture this: a clammy Nicolas Cage sits hunched forward in the driver’s seat of a $5m hypercar, gripping the top of the steering wheel and staring at an undefined point just beyond the camera.
His grip on the wheel tightens and he punches the accelerator.
In a cacophony of protesting rubber and tire smoke, he’s Gone in 60 Seconds.
Sound familiar? I’m making a tenuous but spellbinding opening remark to get our blood flowing about advertising. Not just advertising in general but also, more specifically, patient recruitment advertising.